Providing Market Intelligence for 40 Years

In The News

Netflix, Inc. (NFLX): William Blair's Bull Case Points To $185 Price Target

William Blair upgraded Netflix, Inc. (NASDAQ:NFLX) to Outperform in August 2016 and believes there continues to be upside potential for the streaming video leader. Through William Blair's research, it believes that Netflix has a meaningful leg up on original programming within the over-the-top (OTT) streaming environment and suggest that these advantages might be underappreciated by investors. Moreover, contrary to some, William Blair believes OTT streaming still has plenty of room to grow both domestically and internationally, and Netflix is well positioned to benefit from this secular growth. Parks Associates estimates that more than 60% of broadband households in the United States subscribe to at least one subscription-video-on-demand (SVOD) service. William Blair believes the long-term penetration opportunity is 90% in the United States, in line with pay TV today.

From the article "Netflix, Inc. (NFLX): William Blair's Bull Case Points To $185 Price Target" by www.smartstocknews.com

Previously In The News

The Caregiving Boom: Where the Job Opportunities Are

Some 117 million Americans are expected to need caregiving assistance by 2020, according to the recently released Caregiving Innovation Frontiers (CIF) study conducted by AARP and Parks Associates. Ye...

WD Debuts My Passport Studio Portable Drives For Mac Computers

According to research firm Parks Associates, the average U.S. broadband household currently has over 120 GB of digital media and files which is projected to grow to over 1 TB (terabytes) of data by 20...

AT&T-Time Warner Deal Could Spur More Mergers, Scrutiny

Beyond that, AT&T also gets revenue by licensing those movies and TV series to other pay-TV providers and subscription Net TV services such as Netflix. "Video and entertainment will remain the key dri...

TTA’s Week: Digital Health Funding, Execs’ Wish List, ActivePreventive Responds…And Theranos

We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...